Biodexa Pharmaceuticals (BDRX) Assets (2013 - 2025)
Biodexa Pharmaceuticals' (BDRX) quarterly Assets came in at $24.2 million in Q4 2025, up 27.47% year-over-year from $19.0 million in Q4 2024, and up 22.28% quarter-over-quarter from $19.8 million in Q2 2025.
Analysis
Biodexa Pharmaceuticals (BDRX) Assets (2013 - 2025) Analysis & Trends
Biodexa Pharmaceuticals has disclosed Assets across 13 years of filings, most recently posting $24.2 million for Q4 2025.
- In Q4 2025, Assets rose 27.47% year-over-year to $24.2 million; the TTM figure through Dec 2025 stood at $24.2 million (up 27.47% YoY), while the FY2025 annual figure was $24.0 million, up 26.87% from the prior year.
- Assets came in at $24.2 million for Q4 2025 at Biodexa Pharmaceuticals, up from $19.8 million in the prior quarter.
- In the past five years, Assets ranged from a high of $24.2 million in Q4 2025 to a low of $6.5 million in Q4 2022.
- Average Assets over 5 years is $15.1 million, with a median of $15.2 million recorded in 2021.
- Year-over-year, Assets sank 62.77% in 2022 and surged 101.9% in 2023.
- Over 5 years, Assets stood at $17.4 million in 2021, then slumped by 62.77% to $6.5 million in 2022, then jumped by 101.9% to $13.1 million in 2023, then jumped by 44.98% to $19.0 million in 2024, then gained by 27.47% to $24.2 million in 2025.
- Per Business Quant data, the three most recent Assets figures were $24.2 million in Q4 2025, $19.8 million in Q2 2025, and $19.0 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Biodexa Pharmaceuticals | 53.69 Mn | 42.34 Mn | - | 24.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 24.18 Mn |
| Jun 30, 2025 | 19.78 Mn |
| Dec 31, 2024 | 18.97 Mn |
| Jun 30, 2024 | 17.63 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Jun 30, 2023 | 9.96 Mn |
| Dec 31, 2022 | 6.48 Mn |
| Jun 30, 2022 | 12.19 Mn |
| Dec 31, 2021 | 17.41 Mn |
| Jun 30, 2021 | 11.57 Mn |
| Dec 31, 2020 | 12.96 Mn |
| Jun 30, 2020 | 14.90 Mn |
| Dec 31, 2019 | 39.72 Mn |
| Jun 30, 2019 | 36.70 Mn |
| Dec 31, 2018 | 26.31 Mn |
| Jun 30, 2018 | 48.84 Mn |
| Dec 31, 2017 | 65.35 Mn |
| Jun 30, 2017 | 57.86 Mn |
| Dec 31, 2016 | 70.48 Mn |
| Jun 30, 2016 | 81.30 Mn |